strategic partnership and enhance the synergies between the Company and SGAH in order to grow their business in the global market. The total investment of USD 65 million consists of (1) newly issued ordinary
result Million Baht 2018 2017 Sales 2,020.38 1,915.39 Cost of Sales 1,935.80 1,723.37 Gross Margin 84.58 192.02 Gain (loss) on exchange rates 42.47 25.24 Other Incomes 9.30 15.30 Total Revenues 2,072.15
third quarter of year 2018, the Company’s SG&A expenses was Bt. 1,124.11 million or 3.77% of the total sales revenue which decreased from 3.90 % during the third quarter of year 2017. For the nine-month
Registered Capital : 10,000,000 Baht, and Share divided into 1,000,000 ordinary shares, at the par value of 10 Baht per share. Shareholding Structure : The Company holds 100% of the total shares Size of
. ("Dhipaya Bodin") amounting to 28,000,000 shares or 16.67 percent of the total number of ordinary shares of Dhipaya Bodin will be exercised. Approved the shareholders' meeting to be issued in the fourth
completed the payment of the investment of 139.30 million baht, resulting in the company holding 2,551,760 shares of GS, which is equal to 40% of the total Number of issued and paid of GS. Please be informed
the sales system and sales channels to be more efficient. (6) Transaction details Transaction value : Total amount of Baht 17,000,000.- Remuneration policy : - Sales management fee Fees depending on the
Transaction value : Total amount of Baht 23,000,000.- Remuneration policy : - Sales management fee Fees depending on the scope of work, the location, number of jobs and number of sales staff - Information
Seven Hundred Thousand Myanmar Kyat) or THB 145,025,200 (One Hundred Forty Five Million Twenty Five Thousand Two Hundred Thai Baht). Structure Details will be announced in the due course. The total
treatments compared to total revenue from medical treatment for the 3rd quarter of Year 2018 amd 2019, equaled to 76.7% and 70.1% respectively. The major proportion in cost of medical treatments were derived